Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LWP779 in Healthy Participants [Phase 1]

View source ↗

Summary

A Phase 1 study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of LWP779 in healthy participants; ischemic stroke is listed as a r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• LWP779

Snippet

Sponsor: Longwood Pharmaceuticals (Hangzhou) Co., Ltd. | Conditions: Ischemic Stroke | Phase 1 | Status: RECRUITING